{
    "Trade/Device Name(s)": [
        "CLUNGENE Multi-Drug Test Dip Card",
        "CLUNGENE Multi-Drug Test Easy Cup"
    ],
    "Submitter Information": "Hangzhou Clongene Biotech Co., Ltd.",
    "510(k) Number": "K190412",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180349"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL",
        "PTG",
        "QBF"
    ],
    "Summary Letter Date": "March 21, 2019",
    "Summary Letter Received Date": "February 21, 2019",
    "Submission Date": "February 15, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3620",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Methadone test system",
        "Propoxyphene test system"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "misc"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Opiates",
        "Oxycodone",
        "Secobarbital",
        "Methadone",
        "Buprenorphine",
        "Phencyclidine",
        "Methylenedioxymethamphetamine",
        "Tricyclic Antidepressants",
        "EDDP",
        "Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay",
        "Antigen-antibody immunochemistry"
    ],
    "Methodologies": [
        "Immunochromatographic lateral flow assay",
        "Qualitative analysis"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for CLUNGENE Multi-Drug Test Dip Card and Easy Cup, lateral flow immunochromatographic assays for simultaneous qualitative detection of multiple drugs in human urine.",
    "Indications for Use Summary": "For qualitative and simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Opiates, Oxycodone, Secobarbital, Methadone, Buprenorphine, Phencyclidine, Methylenedioxymethamphetamine, Tricyclic Antidepressants, EDDP and Propoxyphene in human urine at specified cutoff concentrations; for over-the-counter in vitro diagnostic use.",
    "fda_folder": "Toxicology"
}